Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
Ola Landgren(Cornell University), Ingemar Turesson(Spanish Head & Neck Cancer Cooperative Group), Malin Hultcrantz(United States Fish and Wildlife Service), Mark P. Purdue(National Institutes of Health), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Ruth M. Pfeiffer(National Cancer Institute), Sydney X. Lu(Memorial Sloan Kettering Cancer Center), Kazunori Murata(Memorial Sloan Kettering Cancer Center), Sean M. Devlin(Memorial Sloan Kettering Cancer Center), Magnus Björkholm(Karolinska University Hospital), Dickran Kazandjian(United States Food and Drug Administration), Lakshmi V. Ramanathan(Memorial Sloan Kettering Cancer Center), Even H Rustad(Memorial Sloan Kettering Cancer Center), Jonathan N. Hofmann(National Institutes of Health), Sham Mailankody(Memorial Sloan Kettering Cancer Center), Neha Korde(United States Fish and Wildlife Service), Katie Thoren(Memorial Sloan Kettering Cancer Center), Theresia Akhlaghi(Memorial Sloan Kettering Cancer Center), Sigurður Y. Kristinsson(University of Iceland), Loredana Santo(Division of Cancer Epidemiology and Genetics), Charlene M. McShane(Queen's University Belfast)
Cited by 97
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k